Grenoble Proteomic/Transcriptomic Platform PDF Print E-mail

Grenoble Medical Proteomic Platform (clinical bias)

Expert in the processing and analysis of clinical assays, this leading proteomic platform capitalizes on its close proximity with Grenoble University Hospital to advance research in proteomics

Overview

Expert in a wide variety of cutting-edge proteomic techniques such as peptidic fractioning using OFF-GEL and quantification by iTRAQ the platform has also developed an excellent reputation for protein analysis of liquid biological samples (plasma for example).

The expertise in analyzing liquid biological samples is due, in no small part, to the team's close working affinity with Grenoble University Hospital.  The combination of cutting-edge equipment available at the platform and its close alliance with Grenoble CHU results in a high-quality medical proteomic service that is of specific interest to private and public sector research organisations. With Grenoble as its base, the platform also has close links with nano and biotech research programmes (Nanobio).

The platform is one of the few centres in France that is able to combine two types of sources of ionization for mass spectrometry and has already managed over 15 highly complex projects (some examples can be found below).

Key Benefitsaa011138_7.jpg

  • Clinical focus: the platform has been developed specifically to manage clinical research programmes
  • Affinity with Grenoble CHU: located at the heart of Grenoble University Hospital, the platform continues to maintain its close working relationship with the CHU, a factor that facilitates the exchange of medical/clinical data as well as enabling access to a biological resource centre.
  • Development of specific techniques relating to clinical samples (plasma, tissues)
  • Specialists in post-marker quantitative techniques (iTRAQ techniques) and multiple proteomic analyses
  • Unique proteomic and peptide separation processes
  • Industrial training sessions: the team can carry out training sessions on request
  • Research contracts established with the platform conform to BPL (bon pratique de laboratoire) standards. The team is currently working towards gaining an ISO accreditation
  • Core competencies acquired around the analysis of complex biological samples, notably in a clinical environment (diagnostic markers, therapeutic targets, marker validation, cohort studies, technological developments)
  • A wide range of cutting-edge equipment available (see list below)

aa024547_20.jpg

Laboratory Infrastructure

The platform boasts an impressive infrastructure (over 20 specialist laboratory machines and applications) including:

  • MALDI TOF TOF mass spectrometer (Abi 4800)
  • Electrospray (4000 QTrap)
  • 1 and 2D Nanochromatographers
  • Multi dimensional HPLC (Dionex)
  • Low pression chromatography system

At a glance: Examples of past/current projects

  • Identification of proteins demonstrating pharmacological activity originating from snake venom
  • Identification of proteins secreted by pulmonary tumor cell lines
  • Characterisation of synthetic peptides demonstrating pharmacological activity
  • Proteome stem cell research within the context of reparative vascular therapy
  • Research into biomarkers in plasma for chronic sleep apnea
  • Validation of tryptic digestion bioreactor in complex biological sample

Potential Applications

  • Protein identification in complex biological samples
  • Post translational modification studies
  • Protein Characterisation
  • Biomarker detection
  • Protein mapping

cc000781_7.jpgQuantative and differential analysis

The platform can use the iTRAQ technique to identify and quantify proteins from different sources in one single experiment. iTRAQ is used in proteomics to study quantitative changes in the proteome.

  • Identification of specific biomarkers
  • Analysis of the effects of drugs
  • Investigation of pathological mechanisms
  • Cinetic analysis
Grenoble Proteomic/Transcriptomic Platform

Manager : Issartel Jean-Paul / F Berger DR CNRS Grenoble Institut des Neurosciences

Equipment
Proteomic analysis
•  SELDI TOF mass spectrometer - ProteinChip SELDI System Enterprise Edition (and associated software)
•  Biomek Robot used to prepare SELDI TOF protein chips
•  Bio-Rad BioPlex Suspension array system

Scientific analysis of nucleic acids (DNA, RNA, Non coding RNA)
•  Robots Spotter
•  Hybridisation oven
•  FUJI Phosphorimager
•  Agilent BioAnalyzer
•  Affymetrix WorkStation (et associated software)

Description of technical competencies
•  Preparation of RNA and QC (RNA and microRNA)
•  Transcriptomic analyses on Affymetrix micro-arrays
•  Analyses of complex proteins in biological samples by SELDI TOF (surface enhanced laser desorption
ionization time of flight) mass spectrometry
•  Research into discriminating markers for biological or pathological phenotypes
•  Pre-treatment of samples for detection of proteins present in small quantities (Proteominer protein
enrichment)
•  Multiplex analyses of proteins (color-coded beads sets xMAP technology)

Focus of themes targeted by the department
Cancer (brain, bladder, leukemia) general or degenerative pathologies (sleep apnea, Parkinson, rheumatoid arthritis), parisites, immunology, oxidative stress, angiogenesis)

Current developments, installation of new technologies
•  MicroRNA analyses by hybridisation
•  Protein microdosages with micro-biopsy tools
•  Genotyping on the Affymetrix platform

Contact
Carole Speziani
04 56 00 60 43
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

TECHNOLOGY FOCUS

TESTIMONIALS

"Thanks to the Optical Imaging Platform we have been able to carry out preliminary trials" JS Sun, DNA Therapeutics
Read more...